Unknown EARLY_PHASE1 INTERVENTIONAL 1-arm NCT04548453

Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions (uSI-ranges)

Sponsor: PreTeL, Inc

Conditions Fetal Distress Labor Long Pregnancy Related

Updated 5 times since 2020 Last updated: Sep 8, 2020 Started: Apr 30, 2021 Primary completion: Oct 31, 2021 Completion: Oct 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Fetal Distress and Labor Long and is currently ongoing. PreTeL, Inc leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Oct 2022 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2022 [monthly]

Not Yet Recruiting EARLY_PHASE1
Oct 2020 — Jan 2021 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PreTeL, Inc

Data source: PreTeL, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States